已收盘 02-06 16:00:00 美东时间
-0.010
-14.53%
Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches in combination with bioengineered human
2024-09-05 20:17